October, 2024
Cyprumed attends 2nd Biotech Austria Summit
January, 2024
Japan patent granted
September – December, 2023
Cyprumed enters into additional pharma collaborations
February, 2023
Cyprumed expands its lab capabilities to strengthen bioanalytics
November, 2022
Austrian Research Promotion Agency (FFG) reports on success stories of funded projects (incl. Cyprumed, Biontech and others) Link to pdf of Cyprumed project
October, 2022
Cyprumed to presented data on ORAL PROTAC DELIVERY at the Protein Degradation & Targetting Undruggables 2022 conference in Basel, Switzerland, October 11th and 12th
July, 2022
Grant of FFG Funding (Österreichische Forschungsförderung)
January, 2022
Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics Read press release online View/Download pdf
September, 2021
Grant of FFG Funding (Österreichische Forschungsförderung)
October, 2020
US Patent granted